Nerve Stimulator Companies
Nerve stimulators are medical devices used to modulate and regulate the activity of nerves in the body. They find applications in various medical fields, including pain management, neurology, and rehabilitation.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Disclaimer: List of key companies in no particular orderLatest Nerve stimulators Companies Update
Apr 2023: The FDA has recently approved an implant that is only a few hairs wide, intended to address the excessive symptoms of chronic pain. Neuspera Medical, the peripheral nerve stimulation device manufacturer, released the regulatory news. To prevent pain impulses from traveling along peripheral nerves, which are found outside of the brain and spinal cord, Neuspera's PNS system is implanted along these nerves, just like other PNS systems. However, Neuspera refers to this more compact technology version as "ultra-miniaturized." Neuspera claims that this equates to a footprint roughly 75 times smaller than existing PNS devices, potentially enabling medical professionals to access more peripheral nervous system regions than they could with larger implants.
Aug 2023: To treat acute peripheral nerve damage, Epineuron has enrolled the first patient in a trial examining their PeriPulse device. In what it claims to be the largest medical device research for nerve regeneration, the Ontario, Canada-based company REGAIN, seeks to enroll 110 patients in total from both Canada and the US. The PeriPulse system is a transient peripheral nerve stimulation tool. It applies direct electrical impulses to the injured nerve during surgery or soon after. The therapy activates growth-associated gene expression through the promotion of neurotrophic factors.
List of Nerve stimulators Key companies in the market
- Boston Scientific Corporation
- Medtronic
- Cochlear Ltd
- St Jude Medical Inc.
- Cyberonics Inc.
- Aleva Neurotherapeutics SA
- NeuroPace Inc.
Nerve Stimulator Market Highlights:
Nerve Stimulator Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
